EyeCon 2026 Banner
|Articles|March 15, 2004

Anti-VEGF drug expands options in treating AMD

Las Vegas-The investigational drug pegaptanib sodium (Macugen, Eyetech Pharmaceuticals) has been shown to stabilize and improve vision and showed effectiveness against all three subtypes of lesions involved in wet age-related macular degeneration (AMD), according to Lawrence J. Singerman, MD.


Latest CME